Alexander Taylor 🇺🇦

Father. Husband. ST6 respiratory/GIM registrar. Pulmonary infection. COYG.

[Alexander Taylor 🇺🇦 @alextaylor2809]

Best day of my life ❤️ 30.07.2022

[𝗗𝗘𝗖 𝗥!𝗖𝗘 @DR41fanpage]

I told you all. It's done 🏆❤️

[Arsenal @Arsenal]

The Arsenal. Your Premier League champions.

[Alexander Taylor 🇺🇦 @alextaylor2809]

Given the latest news from America (remember, ⁦@RCObsGyn⁩ and ⁦@MHRAgovuk⁩ advice is still that paracetamol is safe in pregnancy), this is a heartwarming scientific breakthrough. Incredible science and hopefully light at the end of the tunnel of this cruel disease

[Alexander Taylor 🇺🇦 @alextaylor2809]

Delighted to share our new publication @ERSpublications on the mechanistic action of Trimodulin in #pneumonia! Grateful to have worked with such a brilliant team at @ChariteBerlin. Read it here 👉 https://t.co/UWuYDiUECD

[Alexander Taylor 🇺🇦 @alextaylor2809]

Dipeptidyl peptidase-1 inhibitors in bronchiectasis https://t.co/M6sHOvnLwl

[Alexander Taylor 🇺🇦 @alextaylor2809]

Ugly building but wonderful experience with the fabulous respiratory team 🫁 @RoyalFreeNHS. Now onto the biggest challenge of them all...shared parental leave 👶

[Arsenal Women @ArsenalWFC]

CHAMPIONS OF EUROPE. THE ONLY IN THE LAND ❤️

[Alexander Taylor 🇺🇦 @alextaylor2809]

Gene editing fixes DNA—and treats incurable lung and liver disease | Science | AAAS https://t.co/AEjK4coJ9V

[Alexander Taylor 🇺🇦 @alextaylor2809]

Ethan Nwaneri. Different gravy @Arsenal #COYG

[Don Sin @donsin4]

The full results of AIRLEAF trial for #bronchiectasis. Safely targeting neutrophils is a reality in #bronchiectasis. https://t.co/yuUsSRcj3j

[Don Sin @donsin4]

#Bronchiectasis is characterized by neutrophilic airway inflammation. However, therapeutics that can safely target #neutrophils have been elusive, until now. This brilliant editorial explains why CatC inhibition improves health outcomes in #bronchiectasis
https://t.co/P0GmWZhDsJ

[The Lancet Respiratory Medicine @LancetRespirMed]

New Article: Baseline characteristics of patients in the Chinese #Bronchiectasis Registry (BE-China): a multicentre cohort study

Characteristics of Chinese bronchiectasis patients show differences compared with cohorts in Europe & India

https://t.co/3RWsBPy9OH

@ProfJDChalmers

[The Lancet Respiratory Medicine @LancetRespirMed]

Treating eosinophilic exacerbations of #asthma and #COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial

Read open access here: https://t.co/WJ9R052uiF

@MonaBafadhel @BTSrespiratory @SanjayResp
@kingsmedicine

[Alexander Taylor 🇺🇦 @alextaylor2809]

😞 The sad thing about this is that those youngsters they are influencing now, who claim they are only doing it because its cool and they can quit anytime...will be the same people I see in clinic in 30 years time, explaining their diagnosis of lung cancer https://t.co/T7Bhl9zgy3

[Alexander Taylor 🇺🇦 @alextaylor2809]

@nikkismallcombe @RSMResp I did nearly exactly the same and can confirm the RSM course is excellent. The only other thing I would throw into the mix is the Liverpool Thoracic Radiology Course, also very good!

[Alexander Taylor 🇺🇦 @alextaylor2809]

@Medic_Russell Total admiration and respect for you guys. Coming back to med reg nights after a year of tertiary ivory towerdom. So impressed with ED resilience in face of intolerable strain. Hang in there

[Alexander Taylor 🇺🇦 @alextaylor2809]

@oli_m_sims Congratulations. I had something similar happen to me at ST training. It makes the achievement all the sweeter. Enjoy!

[Alexander Taylor 🇺🇦 @alextaylor2809]

@danfurmedge @RBandH @RoyalFreeNHS It's as much of a shock to me as you!

[Alexander Taylor 🇺🇦 @alextaylor2809]

And just like that it is goodbye to the @RBandH . Gone in a flash but never forgotten. Next up ST6 (when did that happen 😱) @RoyalFreeNHS 🫁
#respisbest

[Alexander Taylor 🇺🇦 @alextaylor2809]

@CamillaRhead @AminaJaffer3 @RBandH @RoyalFreeNHS #poopatrol ? #alcoholisbad ?